SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-024139
Filing Date
2021-09-30
Accepted
2021-09-30 06:11:28
Documents
14
Period of Report
2021-09-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 33121
2 ex99-1.htm EX-99.1 17909
3 ex99-1_001.jpg GRAPHIC 6099
  Complete submission text file 0001493152-21-024139.txt   239575

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aim-20210927.xsd EX-101.SCH 3025
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aim-20210927_lab.xml EX-101.LAB 34916
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aim-20210927_pre.xml EX-101.PRE 22790
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3664
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 211293498
SIC: 2836 Biological Products, (No Diagnostic Substances)